uniQure is an innovative gene therapy company focused on rare genetic diseases. uniQure’s lead product is AMT-061, a drug to treat Hemophilia B, a serious rare inherited disease characterized by insufficient blood clotting. A pivotal study of AMT-061 for the treatment of patients with severe and moderately severe hemophilia B began enrolling in June 2018.
Stepping Stones operates intimate, high-quality private nursing homes with 24/7 specialized healthcare and residential services to elderly patients suffering from Alzheimer’s disease.The Gilde investment enables Stepping Stones to become the first national chain of private nursing homes specialized in dementia in the Netherlands.
Fysius is a chain of clinics for patients suffering from lower-back and related pains. With over 35,000 treated patients annually, Fysius is the largest specialized clinic for back pain in the Netherlands. Gilde supported Fysius with the further expansion of locations and the optimization of its quality of care.
Inova Labs markets portable oxygen concentrators for patients suffering from respiratory conditions such as COPD or asthma. Portable oxygen concentrators like the LifeChoice® Activox can give patients their freedom back to engage in regular daily activities. Gilde actively supports the international marketing and sales activities of Inova Labs.
Definiens is the leading provider of image analysis for digital pathology. Definiens’ revolutionary approach provides unprecedented accuracy which helps physicians select the best cancer treatment for every cancer patient.